PeterMarcusRavdinMD
Oncology • San Antonio, TXAssistant Professor, Medicine, University of Texas Medical School, San Antonio
Dr. Ravdin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
Zeller 4th Floor
San Antonio, TX 78229Phone+1 210-450-3003Fax+1 210-450-1100
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1984 - 1987- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1981 - 1984
University of Miami Leonard M. Miller School of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1988 - 2026
WI State Medical License 1982 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer Start of enrollment: 1994 Aug 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Publications & Presentations
PubMed
- 827 citationsThe HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized MedicineJeffrey S. Ross, Elzbieta A. Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin
The Oncologist. 2009-04-01 - 1498 citationsAmerican Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerLyndsay Harris, Herbert A. Fritsche, Robert G. Mennel, Larry Norton, Peter M. Ravdin
Journal of Clinical Oncology. 2007-11-20 - 1318 citationsAdjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain
The New England Journal of Medicine. 2018-06-03
Journal Articles
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerMatthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine
Press Mentions
How the Evolving Link Between Science and Advocacy at SABCS Has Grown Even StrongerFebruary 10th, 2013
Two Drugs Appear to Delay Progression of Breast CancerDecember 7th, 2011- Reversing Trend, Big Drop Is Seen in Breast CancerDecember 15th, 2006
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
